These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6140277)

  • 41. Oral metoprolol therapy in dilated cardiomyopathy: hemodynamic evidence for improved diastolic function accompanying amelioration of symptoms.
    Sethi KK; Nair M; Arora R; Khalilullah M
    Int J Cardiol; 1990 Dec; 29(3):317-22. PubMed ID: 2283189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study.
    Circulation; 2000 Feb; 101(4):378-84. PubMed ID: 10653828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.
    Wiklund I; Waagstein F; Swedberg K; Hjalmarsson A
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):361-8. PubMed ID: 8877080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies.
    Waagstein F
    Heart Vessels Suppl; 1991; 6():18-28. PubMed ID: 1687923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy.
    Anderson JL; Lutz JR; Gilbert EM; Sorensen SG; Yanowitz FG; Menlove RL; Bartholomew M
    Am J Cardiol; 1985 Feb; 55(4):471-5. PubMed ID: 2857523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.
    Silke B; Thompson A; Leitch A; Riddell JG
    Br J Clin Pharmacol; 1995 Jul; 40(1):37-42. PubMed ID: 8527266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early reduction in plasma norepinephrine during beta-blocking therapy with metoprolol in chronic heart failure.
    Santostasi G; Fraccarollo D; Dorigo P; Egloff C; Miraglia G; Marinato PG; Villanova C; Fasoli G; Maragno I
    J Card Fail; 1998 Sep; 4(3):177-84. PubMed ID: 9754588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
    Taniguchi Y; Ueshima K; Chiba I; Segawa I; Kobayashi N; Saito M; Hiramori K
    Chest; 2003 Sep; 124(3):954-61. PubMed ID: 12970023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of the effect of bisoprolol in dilated cardiomyopathy.
    Nyolczas N; Dekány M; Fiók J; Prëda I
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):543-50. PubMed ID: 11101203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
    Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
    J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-1-selectivity is not essential to achieve therapeutic efficacy with beta-blockade therapy for idiopathic dilated cardiomyopathy.
    Yoshikawa T; Handa S; Akaishi M; Mitamura H; Ogawa S
    Cardiology; 1995; 86(3):217-23. PubMed ID: 7614494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
    Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
    Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON
    Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.
    Gullestad L; Manhenke C; Aarsland T; Skårdal R; Fagertun H; Wikstrand J; Kjekshus J
    Eur J Heart Fail; 2001 Aug; 3(4):463-8. PubMed ID: 11511433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Nemanich JW; Veith RC; Abrass IB; Stratton JR
    Am J Cardiol; 1990 Oct; 66(10):843-8. PubMed ID: 2220583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.